| Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy PWG Mallon, J Miller, DA Cooper, A Carr Aids 17 (7), 971-979, 2003 | 418 | 2003 |
| Microglial cells: the main HIV-1 reservoir in the brain C Wallet, M De Rovere, J Van Assche, F Daouad, S De Wit, V Gautier, ... Frontiers in cellular and infection microbiology 9, 362, 2019 | 275 | 2019 |
| Persistent endotheliopathy in the pathogenesis of long COVID syndrome H Fogarty, L Townsend, H Morrin, A Ahmad, C Comerford, E Karampini, ... Journal of thrombosis and haemostasis 19 (10), 2546-2553, 2021 | 266 | 2021 |
| Molecular Diagnosis of Infective Endocarditis? A New Duke's Criterion B Millar, J Moore, P Mallon, J Xu, M Crowe, R McClurg, D Raoult, J Earle, ... Scandinavian journal of infectious diseases 33 (9), 673-680, 2001 | 238 | 2001 |
| In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA PWG Mallon, P Unemori, R Sedwell, A Morey, M Rafferty, K William, ... Journal of Infectious Diseases 191 (10), 1686-1696, 2005 | 210 | 2005 |
| HIV and HAART-associated dyslipidemia ER Feeney, PWG Mallon The open cardiovascular medicine journal 5, 49, 2011 | 209 | 2011 |
| Efficacy and safety of COVID‐19 vaccines Cochrane Emergency and Critical Care Group, C Graña, L Ghosn, ... Cochrane Database of Systematic Reviews 2023 (3), 1996 | 202 | 1996 |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 154 | 2020 |
| Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs A Ait-Ammar, A Kula, G Darcis, R Verdikt, S De Wit, V Gautier, ... Frontiers in microbiology 10, 3060, 2020 | 144 | 2020 |
| COVID-19 induces a hyperactive phenotype in circulating platelets SP Comer, S Cullivan, PB Szklanna, L Weiss, S Cullen, S Kelliher, ... PLoS biology 19 (2), e3001109, 2021 | 138 | 2021 |
| Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapy A Winston, J Amin, PWG Mallon, D Marriott, A Carr, DA Cooper, S Emery HIV medicine 7 (2), 105-111, 2006 | 117 | 2006 |
| Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia A Carr, A Morey, P Mallon, D Williams, DR Thorburn The Lancet 357 (9266), 1412-1414, 2001 | 111 | 2001 |
| Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe R Moore, D O’shea, T Geoghegan, PWG Mallon, G Sheehan Infection 41, 681-686, 2013 | 109 | 2013 |
| Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation SE Ward, GF Curley, M Lavin, H Fogarty, E Karampini, NL McEvoy, ... British journal of haematology 192 (4), 714-719, 2021 | 108 | 2021 |
| Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men—a randomized, placebo-controlled study PWG Mallon, J Miller, JC Kovacic, J Kent-Hughes, R Norris, K Samaras, ... Aids 20 (7), 1003-1010, 2006 | 106 | 2006 |
| Increased platelet reactivity in HIV-1–infected patients receiving abacavir-containing antiretroviral therapy CS Satchell, JA O’Halloran, AG Cotter, AJ Peace, EF O’Connor, ... Journal of Infectious Diseases 204 (8), 1202-1210, 2011 | 103 | 2011 |
| Oxidative stress during acute respiratory exacerbations in cystic fibrosis LT McGrath, P Mallon, L Dowey, B Silke, E McClean, M McDonnell, ... Thorax 54 (6), 518-523, 1999 | 101 | 1999 |
| Darunavir concentrations in cerebrospinal fluid and blood in HIV-1–infected individuals A Yilmaz, A Izadkhashti, RW Price, PW Mallon, M De Meulder, ... AIDS Research and Human Retroviruses 25 (4), 457-461, 2009 | 96 | 2009 |
| Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults … JI Bernardino, A Mocroft, PW Mallon, C Wallet, J Gerstoft, C Russell, ... The lancet HIV 2 (11), e464-e473, 2015 | 92 | 2015 |
| Weight gain before and after switch from TDF to TAF in a US cohort study PWG Mallon, L Brunet, RK Hsu, JS Fusco, KC Mounzer, G Prajapati, ... African Journal of Reproduction and Gynaecological Endoscopy 24 (4), e25702, 2021 | 87 | 2021 |
Naveed SattarUniversity of GlasgowVerified email at glasgow.ac.uk
